Scripps Research Receives $3.2 Million Grant to Study Type 1 Diabetes
Table of Contents
Publication Date: 2025/10/29 20:42:13
Understanding the Autoimmune Attack in Type 1 Diabetes
Luc Teyton, professor in the Department of Immunology and Microbiology at Scripps Research, has received a five-year, $3.2 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to investigate the causes of type 1 diabetes and develop potential treatments to reverse or prevent the disease.
Type 1 diabetes is an autoimmune disease where the immune system attacks the body’s insulin-producing cells. Insulin is a critical hormone that regulates blood sugar. Approximately 1.6 million Americans live wiht type 1 diabetes. While genetics contribute to susceptibility, the exact trigger for the autoimmune attack remains unclear.
The Role of Vascular-Associated Fibroblastic Cells (VAFs)
Professor Teyton is collaborating with Assistant professor joseph Jardine to study vascular-associated fibroblastic cells (VAFs) and their role in the development of type 1 diabetes. VAFs,though rare,function as molecular peacekeepers within the pancreas,actively protecting insulin-producing cells from immune system attacks.
Early research from Teyton’s lab suggests that type 1 diabetes may develop when VAFs become overwhelmed. This allows the immune system to activate and destroy the insulin-producing cells, disrupting the body’s blood sugar balance.
Type 1 diabetes substantially impacts the lives of patients and their families. Understanding the underlying mechanisms of this disease is crucial for developing effective therapies.
Research Focus and Potential Therapies
The research will focus on understanding how VAFs maintain immune tolerance in the pancreas and what factors cause them to fail. By identifying these factors, scientists hope to develop therapies that can strengthen VAF function or restore immune tolerance, perhaps reversing or preventing type 1 diabetes.
Key takeaways
- Type 1 diabetes is an autoimmune disease affecting approximately 1.6 million Americans.
- Vascular-associated fibroblastic cells (VAFs) play a crucial role in protecting insulin-producing cells.
- The research aims to understand why VAFs fail, leading to the autoimmune attack.
- The ultimate goal is to develop therapies to reverse or prevent type 1 diabetes.